Friday 6 November 2026 Export ELAN’s income statement to Excel — free account

Elanco Animal Health Incorporated

ELAN Healthcare Drug Manufacturers Specialty & Generic

Elanco Animal Health Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 6.22% from fiscal 2024.

Revenue: +10.2%
EPS: +450.0%
Free cash flow: +35.6%
Total debt: −6.91%

Quarter to June 2026, against a year earlier

23.74 1.57 −6.20%

Follow ELAN

Alert me

Market cap: $11.8B
P/E: 0.0×
Fwd P/E: 161×
Dividend yield: —
F-score: 5/9
Altman Z: 1.28
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Elanco Animal Health Incorporated (ELAN) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Elanco Animal Health Incorporated (ELAN) trades at a P/S ratio of 2.4×. Over the past ten years it has ranged from 0.0× (September 2018) to 5.3× (October 2020); the current reading is higher than 47% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.1× and below the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ELAN/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Elanco Animal Health Incorporated P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ELAN/metrics/ps-ratio">Elanco Animal Health Incorporated (ELAN) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	2.4×	76.78%
FY2024	1.3×	(17.41%)
FY2023	1.6×	19.35%
FY2022	1.4×	(52.89%)
FY2021	2.9×	(29.87%)
FY2020	4.1×	16.96%
FY2019	3.5×	9.72%
FY2018	3.2×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/S ratio	Change
Jun 2026	2.4×	0.60%
Mar 2026	2.4×	2.17%
Dec 2025	2.4×	9.32%
Sep 2025	2.2×	37.81%
31 more quarters	Free account

Against its own ten years

Low 0.0× High 5.3×

Ten-year median 2.4×

Current reading's percentile 47

Company	P/S ratio
VTRS Viatris Inc. compare	1.5×
AMRX AMNEAL PHARMACEUTICALS, INC. compare	2.0×
HIMS Hims & Hers Health, Inc. compare	2.2×
ELAN Elanco Animal Health Incorporated	2.4×
RDY Dr. Reddy's Laboratories Ltd compare	3.6×
LNTH Lantheus Holdings, Inc. compare	4.2×
ALKS Alkermes plc compare	4.3×
NBIX Neurocrine Biosciences, Inc. compare	4.4×
KNSA Kiniksa Pharmaceuticals International, plc compare	7.3×
Drug Manufacturers Specialty & Generic industry median	2.1×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Elanco Animal Health Incorporated (ELAN) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ELAN

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ELAN

Stockrow Weekly